~ Strong demand for the LNG HPDI trucks drives 125% Q2 revenue growth for Cespira ~
“The second quarter marked another important step forward in Westport’s transformation, with two developments that reinforce both the commercial momentum behind Cespira and our ability to fund the next phase of our strategy. Cespira, our joint venture with Volvo Group, continued to scale in the quarter, delivering significant year-over-year quarterly revenue growth, supported by increased customer orders for the HPDI™ fuel system, with revenue up 125% and gross profit improvement of 298% at the joint venture level, compared to the prior-year quarter. These results reflect the growing market acceptance of HPDI as a practical, affordable, high-performance solution for heavy-duty transportation.
We are encouraged by the market drivers supporting this growth. The price advantage of LNG versus diesel fuel has remained resilient in
That relevance was further strengthened in June when Cespira and
We also took a meaningful step in strengthening Westport’s financial position. In June, we completed a private placement that provided initial gross proceeds of approximately
For fleet operators, the path forward must be pragmatic. It must be built on stable economics, proven performance and infrastructure that exists today. By pairing Westport’s high-pressure CNG fuel storage solution with Cespira’s HPDI fuel system, we believe we can help North American fleets save money, reduce emissions and address energy security issues with a natural gas and renewable natural gas powertrain system, while maintaining a pathway to hydrogen as the fuel's economics and infrastructure mature. This is the foundation of our North American CNG strategy: meeting operators where they are today while building a practical, affordable, scalable pathway to the lower-emission freight systems of tomorrow.”
Second Quarter 2026 Highlights
- Revenues for the second quarter of 2026 decreased to
$2.7 million compared to$12.5 million in the same quarter last year. As planned, our Heavy-Duty OEM segment ended its transitional service agreement with Cespira at the end of Q2 2025 resulting in reduction in revenue when comparing period over period. - Cespira delivered strong financial performance, driven by significant growth in product, aftermarket, and service revenue. For the three months ended
June 30, 2026 , revenue increased by$15.1 million or 125% compared to the prior year quarter. Cespira reduced its net loss by$4.4 million and reliance on funding from its partners in the quarter. Westport reduced its capital contributions to Cespira in the quarter from$4.2 million to$3.5 million . - For the three months ended
June 30, 2026 , our High-Pressure Controls segment decreased its revenue by$0.2 million or 6% compared to the prior year quarter. - Net loss from continuing operations of
$11.4 million for the quarter compared to a net loss from continuing operations of$5.1 million for the same quarter last year. The increase in net loss in the current quarter was primarily driven by the loss recognized for the change in fair value of the warrant liabilities, financing transaction costs, and foreign exchange loss. In the prior year quarter, we had a foreign exchange gain of$4.2 million . - Adjusted EBITDA1 of negative
$6.3 million compared to negative$1.0 million for the same period in 2025. The increase in negative adjusted EBITDA was primarily driven by an increase in operating loss for the quarter partially offset by a decrease in the loss from investments accounted for by the equity method. Included in the prior year quarter's adjusted EBITDA was our discontinued operations' performance, which included an operating profit of$3.1 million for the three months endedJune 30, 2025 . - Cash and cash equivalents were
$23.9 million for the second quarter of 2026. Cash used in operating activities from continuing operations was$4.6 million , primarily driven by operating losses in the quarter and changes in working capital. Cash used in investing activities from continuing operations primarily consisted of capital contributions to Cespira of$3.5 million . Cash provided by financing activities from continuing operations were primarily driven by the financing transaction partially offset by debt repayments of$1.0 million in the quarter. - Long term debt, including the current portion, was
$1.0 million as atJune 30, 2026 , compared to$2.9 million atDecember 31, 2025 .
______________________
1 Adjusted earnings before interest, taxes and depreciation is a non-GAAP measure. Please refer to NON-GAAP FINANCIAL MEASURES in Westport’s Management Discussion and Analysis for the reconciliation.
| CONSOLIDATED RESULTS | ||||||||||||||||
| ($ in thousands, except per share amounts) | Increase / (Decrease) % | Increase / (Decrease) % | ||||||||||||||
| 2Q26 | 2Q25 | 1H26 | 1H25 | |||||||||||||
| Revenues | $ | 2,717 | $ | 12,498 | (78 | )% | $ | 5,002 | $ | 19,821 | (75 | )% | ||||
| Gross Profit | 133 | 842 | (84 | )% | 649 | 2,377 | (73 | )% | ||||||||
| Gross Margin %(2) | 5 | % | 7 | % | 13 | % | 12 | % | ||||||||
| Loss from Investments Accounted for by the Equity Method(1) | (1,283 | ) | (3,686 | ) | (65 | )% | (2,664 | ) | (7,570 | ) | (65 | )% | ||||
| Net Loss from Continuing Operations | (11,375 | ) | (5,053 | ) | (125 | )% | (17,082 | ) | (10,348 | ) | (65 | )% | ||||
| Net Loss from Discontinued Operations | — | (29,291 | ) | 100 | % | — | (26,447 | ) | 100 | % | ||||||
| Net Loss | (11,375 | ) | (34,344 | ) | 67 | % | (17,082 | ) | (36,795 | ) | 54 | % | ||||
| Net Loss per Share - Basic & Diluted | $ | (0.64 | ) | $ | (1.98 | ) | 68 | % | $ | (0.97 | ) | $ | (2.12 | ) | 54 | % |
| EBITDA(2) | $ | (10,823 | ) | $ | (30,049 | ) | 64 | % | $ | (16,857 | ) | $ | (30,184 | ) | 44 | % |
| Adjusted EBITDA(2) | $ | (6,273 | ) | $ | (1,017 | ) | (517 | )% | $ | (11,132 | ) | $ | (1,024 | ) | (987 | )% |
(1) This includes income or loss from our investments in Cespira joint ventures.
(2) Gross margin, EBITDA and Adjusted EBITDA are non-GAAP measures. Please refer to GAAP and NON-GAAP FINANCIAL MEASURES for the reconciliation to equivalent GAAP measures and limitations on the use of such measures.
Segment Information
High-Pressure Controls
Revenue for the three months ended
Gross profit was
Heavy-Duty OEM
The segment's transitional service agreement with Cespira ended in Q2 2025 and, as a result, the segment did not have any sales activity in the quarter.
Selected Cespira Statements of Operations Data
We account for Cespira using the equity method of accounting. However, due to its significance to our long-term strategy and operating results, we disclose selected Cespira financial information in our interim financial statements for the three and six months ended
The following table sets forth a summary of the financial results of Cespira for the three and six months ended
| Three months ended | Change | Six months ended | Change | |||||||||||||||||||||||||||
| (in thousands of | 2026 | 2025 | $ | % | 2026 | 2025 | $ | % | ||||||||||||||||||||||
| Product revenue | $ | 18,918 | $ | 8,344 | $ | 10,574 | 127 | % | $ | 34,049 | $ | 18,450 | $ | 15,599 | 85 | % | ||||||||||||||
| Aftermarket revenue | $ | 5,517 | $ | 2,647 | $ | 2,870 | 108 | % | 9,878 | 5,719 | $ | 4,159 | 73 | % | ||||||||||||||||
| Service revenue | $ | 2,636 | $ | 1,029 | 1,607 | 156 | % | 5,393 | 4,650 | 743 | 16 | % | ||||||||||||||||||
| Total revenue | $ | 27,071 | $ | 12,020 | 15,051 | 125 | % | 49,320 | 28,819 | 20,501 | 71 | % | ||||||||||||||||||
| Gross profit1 | $ | 3,814 | $ | (1,926 | ) | 5,740 | 298 | % | 5,390 | (1,411 | ) | 6,801 | 482 | % | ||||||||||||||||
| Gross margin % | 14 | % | (16 | )% | 11 | % | (5 | )% | ||||||||||||||||||||||
| Research & development | $ | 1,182 | $ | 1,888 | (706 | ) | (37 | )% | 2,662 | 4,890 | (2,228 | ) | (46 | )% | ||||||||||||||||
| Selling, general, & administrative | $ | 3,590 | $ | 3,014 | 576 | 19 | % | 6,114 | 6,037 | 77 | 1 | % | ||||||||||||||||||
| Operating loss | $ | (2,120 | ) | $ | (6,843 | ) | 4,723 | (69 | )% | (4,710 | ) | (13,840 | ) | 9,130 | (66 | )% | ||||||||||||||
| Net loss | $ | (2,375 | ) | $ | (6,746 | ) | 4,371 | (65 | )% | (4,897 | ) | (13,744 | ) | 8,847 | (64 | )% | ||||||||||||||
(1)Gross margin are non-GAAP measures. Please refer to GAAP and NON-GAAP FINANCIAL MEASURES for the reconciliation to equivalent GAAP measures and limitations on the use of such measures.
Product Revenue for the three and six months ended
Aftermarket Revenue for the three and six months ended
Service Revenue for the three and six months ended
Gross profit was
Cespira had an operating loss of
Liquidity and Going Concern
As at
Based on our projected capital expenditures, debt servicing obligations and operating requirements under our current business plan, we are projecting that our cash and cash equivalents will not be sufficient to fund our operations through the next twelve months from the date of the issuance of our Q2 2026 MD&A. These conditions raise substantial doubt about Westport's ability continue as a going concern within one year after the date that our Q2 2026 MD&A is issued.
Management is currently evaluating several different options to improve Westport's liquidity position, including raising funds from the public markets and borrowing debt or other financing alternatives. These plans are not final and are subject to market and other conditions not within our control. As such, there can be no assurances that Westport will be successful in obtaining sufficient funding. Accordingly, we concluded under the accounting standards that these plans do not alleviate the substantial doubt about Westport's ability to continue as a going concern.
Conference call
Westport has scheduled a conference call for
The live webcast of the conference call can be accessed through the Westport website at https://investors.westport.com/.
Participants may register up to 60 minutes before the event by clicking on the call link and completing the online registration form. Upon registration, the user will receive dial-in info and a unique PIN, along with an email confirming the details.
The webcast will be archived on Westport’s website at https://investors.westport.com.
Financial Statements and Management's Discussion and Analysis
To view Westport full financials for the second quarter ended
About Westport
Westport is a technology and innovation company connecting synergistic technologies to power a cleaner tomorrow. As a leading supplier of affordable, alternative fuel, low-emissions transportation technologies, we design, manufacture, and supply advanced components and systems that enable the transition from traditional fuels to cleaner energy solutions.
Our proven technologies support a wide range of alternative fuels – including natural gas, renewable natural gas, and hydrogen – empowering OEMs and commercial transportation industries to meet performance demands, regulatory requirements, and climate targets in a cost-effective way. With decades of expertise and a commitment to engineering excellence, Westport is helping our partners achieve sustainability goals—without compromising performance or cost-efficiency – making clean, scalable transport solutions a reality.
Westport is headquartered in
GAAP and NON-GAAP FINANCIAL MEASURES
Our financial statements are prepared in accordance with
Segment Information
EBITDA and Adjusted EBITDA are intended to provide additional information to investors and analysts and do not have any standardized definition under
Segment earnings or losses before income taxes, interest, depreciation, and amortization ("Segment EBITDA") is the measure of segment profitability used by the Company. The accounting policies of our reportable segments are the same as those applied in our consolidated financial statements. Management prepared the financial results of the Company's reportable segments on basis that is consistent with the manner in which Management internally disaggregates financial information to assist in making internal operating decisions. Certain common costs and expenses, primarily corporate functions, among segments differently than we would for stand-alone financial information prepared in accordance with GAAP. These include certain costs and expenses of shared services, such as IT, human resources, legal, finance and supply chain management. Segment EBITDA is not defined under
| Three months ended | |||||||||||
| High-Pressure Controls | Cespira | Total Segment | |||||||||
| Revenue | $ | 2,717 | $ | 27,071 | $ | 29,788 | |||||
| Cost of revenue | 2,584 | 23,257 | 25,841 | ||||||||
| Gross profit | 133 | 3,814 | 3,947 | ||||||||
| Operating expenses: | |||||||||||
| Research & development | 790 | 1,182 | 1,972 | ||||||||
| General & administrative | 561 | 2,969 | 3,530 | ||||||||
| Sales & marketing | 131 | 621 | 752 | ||||||||
| Depreciation & amortization | 11 | 899 | 910 | ||||||||
| 1,493 | 5,671 | 7,164 | |||||||||
| Add back: Depreciation & amortization | 221 | 986 | 1,207 | ||||||||
| Segment EBITDA | $ | (1,139 | ) | $ | (871 | ) | $ | (2,010 | ) | ||
| Three months ended | ||||||||||||||
| High-Pressure Controls & Systems | Heavy-Duty OEM | Cespira | Total Segment | |||||||||||
| Revenue | $ | 2,896 | $ | 9,602 | $ | 12,020 | $ | 24,518 | ||||||
| Cost of revenue | 2,791 | 8,865 | 13,946 | 25,602 | ||||||||||
| Gross profit | 105 | 737 | (1,926 | ) | (1,084 | ) | ||||||||
| Operating expenses: | ||||||||||||||
| Research & development | 1,552 | 22 | 1,888 | 3,462 | ||||||||||
| General & administrative | 386 | 34 | 2,692 | 3,112 | ||||||||||
| Sales & marketing | 23 | 3 | 322 | 348 | ||||||||||
| Depreciation & amortization | 59 | — | 860 | 919 | ||||||||||
| 2,020 | 59 | 5,762 | 7,841 | |||||||||||
| Add back: Depreciation & amortization | 172 | — | 772 | 944 | ||||||||||
| Segment EBITDA | $ | (1,743 | ) | $ | 678 | $ | (6,916 | ) | $ | (7,981 | ) | |||
| Six months ended | |||||||||||
| High-Pressure Controls | Cespira | Total Segment | |||||||||
| Revenue | $ | 5,002 | $ | 49,320 | $ | 54,322 | |||||
| Cost of revenue | 4,353 | 43,930 | 48,283 | ||||||||
| Gross profit | 649 | 5,390 | 6,039 | ||||||||
| Operating expenses: | |||||||||||
| Research and development | 1,738 | 2,662 | 4,400 | ||||||||
| General and administrative | 1,112 | 5,232 | 6,344 | ||||||||
| Sales and marketing | 226 | 882 | 1,108 | ||||||||
| Depreciation and amortization | 96 | 1,773 | 1,869 | ||||||||
| 3,172 | 10,549 | 13,721 | |||||||||
| Add back: Depreciation and amortization1 | 408 | 1,935 | 2,343 | ||||||||
| Segment EBITDA | $ | (2,115 | ) | $ | (3,224 | ) | $ | (5,339 | ) | ||
| Six months ended | ||||||||||||||
| High-Pressure Controls | Heavy-Duty OEM | Cespira | Total Segment | |||||||||||
| Revenue | $ | 4,786 | $ | 15,035 | $ | 28,819 | $ | 48,640 | ||||||
| Cost of revenue | 4,168 | 13,276 | 30,230 | 47,674 | ||||||||||
| Gross profit | 618 | 1,759 | (1,411 | ) | 966 | |||||||||
| Operating expenses: | ||||||||||||||
| Research and development | 2,734 | 133 | 4,890 | 7,757 | ||||||||||
| General and administrative | 705 | 99 | 5,419 | 6,223 | ||||||||||
| Sales and marketing | 150 | 23 | 618 | 791 | ||||||||||
| Depreciation and amortization | 115 | — | 1,590 | 1,705 | ||||||||||
| 3,704 | 255 | 12,517 | 16,476 | |||||||||||
| Add back: Depreciation and amortization1 | 298 | — | 2,392 | 2,690 | ||||||||||
| Segment EBITDA | $ | (2,788 | ) | $ | 1,504 | $ | (11,536 | ) | $ | (12,820 | ) | |||
| Three months ended | |||||||||||||
| Total Segment | Less: Cespira | Add: Corporate & unallocated | Total Consolidated | ||||||||||
| Revenue | $ | 29,788 | $ | 27,071 | $ | — | $ | 2,717 | |||||
| Cost of revenue | 25,841 | 23,257 | — | 2,584 | |||||||||
| Gross profit | 3,947 | 3,814 | — | 133 | |||||||||
| Operating expenses: | |||||||||||||
| Research & development | 1,972 | 1,182 | 421 | 1,211 | |||||||||
| General & administrative | 3,530 | 2,969 | 3,613 | 4,174 | |||||||||
| Sales & marketing | 752 | 621 | 93 | 224 | |||||||||
| Depreciation & amortization | 910 | 899 | 34 | 45 | |||||||||
| 7,164 | 5,671 | 4,161 | 5,654 | ||||||||||
| Equity loss | — | — | (1,283 | ) | (1,283 | ) | |||||||
| Three months ended | |||||||||||||||
| Total Segment | Less: Cespira | Add: Corporate & unallocated | Total Consolidated | ||||||||||||
| Revenue | $ | 24,518 | $ | 12,020 | $ | — | $ | 12,498 | |||||||
| Cost of revenue | 25,602 | 13,946 | — | 11,656 | |||||||||||
| Gross profit | (1,084 | ) | (1,926 | ) | — | 842 | |||||||||
| Operating expenses: | |||||||||||||||
| Research & development | 3,462 | 1,888 | — | 1,574 | |||||||||||
| General & administrative | 3,112 | 2,692 | 3,686 | 4,106 | |||||||||||
| Sales & marketing | 348 | 322 | 264 | 290 | |||||||||||
| Depreciation & amortization | 919 | 860 | 47 | 106 | |||||||||||
| 7,841 | 5,762 | 3,997 | 6,076 | ||||||||||||
| Equity loss | — | — | (3,686 | ) | (3,686 | ) | |||||||||
| Six months ended | |||||||||||||
| Total Segment | Less: Cespira | Add: Corporate & unallocated | Total Consolidated | ||||||||||
| Revenue | $ | 54,322 | $ | 49,320 | $ | — | $ | 5,002 | |||||
| Cost of revenue | 48,283 | 43,930 | — | 4,353 | |||||||||
| Gross profit | 6,039 | 5,390 | — | 649 | |||||||||
| Operating expenses: | |||||||||||||
| Research and development | 4,400 | 2,662 | 696 | 2,434 | |||||||||
| General and administrative | 6,344 | 5,232 | 5,896 | 7,008 | |||||||||
| Sales and marketing | 1,108 | 882 | 205 | 431 | |||||||||
| Depreciation and amortization | 1,869 | 1,773 | 59 | 155 | |||||||||
| 13,721 | 10,549 | 6,856 | 10,028 | ||||||||||
| Equity loss | — | — | (2,664 | ) | (2,664 | ) | |||||||
| Six months ended | ||||||||||||||
| Total Segment | Less: Cespira | Add: Corporate & unallocated | Total Consolidated | |||||||||||
| Revenue | $ | 48,640 | $ | 28,819 | $ | — | $ | 19,821 | ||||||
| Cost of revenue | 47,674 | 30,230 | — | 17,444 | ||||||||||
| Gross profit | 966 | (1,411 | ) | — | 2,377 | |||||||||
| Operating expenses: | ||||||||||||||
| Research and development | 7,757 | 4,890 | — | 2,867 | ||||||||||
| General and administrative | 6,223 | 5,419 | 5,974 | 6,778 | ||||||||||
| Sales and marketing | 791 | 618 | 560 | 733 | ||||||||||
| Depreciation and amortization | 1,705 | 1,590 | 99 | 214 | ||||||||||
| 16,476 | 12,517 | 6,633 | 10,592 | |||||||||||
| Equity loss | — | — | (7,570 | ) | (7,570 | ) | ||||||||
| Reconciliation of Segment EBITDA to Loss before income taxes | Three months ended | Six months ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Total Segment EBITDA | $ | (2,010 | ) | $ | (7,981 | ) | $ | (5,339 | ) | $ | (12,820 | ) | ||||
| Adjustments: | ||||||||||||||||
| Depreciation and amortization1 | 255 | 219 | 467 | 397 | ||||||||||||
| Cespira's Segment EBITDA | (871 | ) | (6,916 | ) | (3,224 | ) | (11,536 | ) | ||||||||
| Loss on investments accounted for under the equity method (note 8) | 1,283 | 3,686 | 2,664 | 7,570 | ||||||||||||
| Corporate and unallocated operating expenses | 4,127 | 3,950 | 6,797 | 6,534 | ||||||||||||
| Foreign exchange gain (loss) | 1,693 | (4,224 | ) | 2,700 | (5,427 | ) | ||||||||||
| Change in fair value of warrant liability | 1,496 | — | 1,496 | — | ||||||||||||
| Financing transaction costs | 1,085 | — | 1,085 | — | ||||||||||||
| Interest on long-term debt | 68 | 166 | 158 | 358 | ||||||||||||
| Interest and other income, net of bank charges | 6 | 147 | (736 | ) | (502 | ) | ||||||||||
| Loss before income taxes in continuing operations | $ | (11,152 | ) | $ | (5,009 | ) | $ | (16,746 | ) | $ | (10,214 | ) | ||||
| Gross Profit and Gross Margin | ||||||||||||||||
| (expressed in thousands of | 2Q26 | 2Q25 | 1Q26 | 1Q25 | ||||||||||||
| Three months ended | ||||||||||||||||
| Revenue | $ | 2,717 | $ | 12,498 | $ | 2,285 | $ | 7,323 | ||||||||
| Less: Cost of revenue | 2,584 | 11,656 | 1,769 | 5,788 | ||||||||||||
| Gross profit | 133 | 842 | 516 | 1,535 | ||||||||||||
| Gross margin % | 5 | % | 7 | % | 23 | % | 21 | % | ||||||||
| EBITDA and Adjusted EBITDA | ||||||||||||||||
| (expressed in thousands of | 2Q26 | 2Q25 | 1Q26 | 1Q25 | ||||||||||||
| Three months ended | ||||||||||||||||
| Income (Loss) before income taxes | $ | (11,152 | ) | $ | (32,671 | ) | $ | (5,594 | ) | $ | (1,872 | ) | ||||
| Interest expense (income), net | 74 | 571 | (652 | ) | (193 | ) | ||||||||||
| Depreciation and amortization | 255 | 2,051 | 212 | 1,930 | ||||||||||||
| EBITDA | (10,823 | ) | (30,049 | ) | (6,034 | ) | (135 | ) | ||||||||
| Stock based compensation | 276 | 451 | 168 | 285 | ||||||||||||
| Unrealized foreign exchange (gain) loss | 1,693 | (2,362 | ) | 1,007 | (456 | ) | ||||||||||
| Severance costs | — | 96 | — | 299 | ||||||||||||
| Loss on disposal of operations | — | 30,183 | — | — | ||||||||||||
| Impairment of long-term investments and long-term assets | — | 664 | — | — | ||||||||||||
| Change in fair value of warrant liability | 1,496 | — | — | — | ||||||||||||
| Financing transaction costs | 1,085 | — | — | — | ||||||||||||
| Adjusted EBITDA | $ | (6,273 | ) | $ | (1,017 | ) | $ | (4,859 | ) | $ | (7 | ) | ||||
Cautionary Note Regarding Forward Looking Statements
This press release contains forward-looking statements, including statements regarding future strategic initiatives and future growth, future of our development programs (including those relating to HPDI and Hydrogen) including testing to the HPDI fuel system, timing of engineering milestones and product launch schedules, scaling our alternative fuel-based solutions, our expectations for 2026 and beyond, including growth expectations, market growth and the demand for our products, the future success of our business and technology strategies, our ability to bolster our balance sheet, fund organic growth and raise additional capital as well as, a shift to operating as a smaller, more efficient organization. These statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties and are based on both the views of management and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activities, performance or achievements expressed in or implied by these forward-looking statements. These risks, uncertainties and assumptions include those related to our revenue growth, operating results, sufficiency of cash resources, industry and products, changes in business strategy, shifts in market demand, the general economy including impacts due to inflation, the effects of competition and pricing pressures, conditions of and access to the capital and debt markets, solvency, governmental policies, trade restrictions or other changes to international trade agreements, sanctions and regulation including the imposition of tariffs, technology innovations, fluctuations in foreign exchange rates, operating expenses, continued reduction in expenses, ability to successfully commercialize new products, the performance of our joint venture, the availability and price of natural gas, new environmental regulations, the acceptance of and shift to natural gas and hydrogen vehicles, the relaxation or waiver of fuel emission standards, the inability of fleets to access capital or government funding to purchase natural gas vehicles, the development of competing technologies, our ability to adequately develop and deploy our technology, the actions and determinations of our joint venture and development partners, supply chain disruptions, commodity price expectations as well as other risk factors and assumptions that may affect our actual results, performance or achievements or financial position discussed in our most recent annual report, Form 20-F and other filings with securities regulators. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they were made. We disclaim any obligation to publicly update or revise such statements to reflect any change in our expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in these forward-looking statements except as required by National Instrument 51-102. The contents of any website, RSS feed or twitter account referenced in this press release are not incorporated by reference herein.
Contact Information
Westport Investor Relations
T: +1 604-718-2046
Condensed Consolidated Interim Balance Sheets (unaudited) (Expressed in thousands of | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents (including restricted cash) | $ | 23,946 | $ | 27,158 | ||||
| Accounts receivable | 6,146 | 10,177 | ||||||
| Inventories | 2,745 | 3,037 | ||||||
| Prepaid expenses | 632 | 1,182 | ||||||
| Total current assets | 33,469 | 41,554 | ||||||
| Long-term investments | 44,028 | 42,714 | ||||||
| Property, plant and equipment | 5,552 | 5,605 | ||||||
| Operating lease right-of-use assets | 1,537 | 1,756 | ||||||
| Other long-term assets | 421 | 2,380 | ||||||
| Total assets | $ | 85,007 | $ | 94,009 | ||||
| Liabilities and shareholders’ equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued liabilities | $ | 16,416 | $ | 17,933 | ||||
| Warrant liabilities | 11,337 | — | ||||||
| Current portion of operating lease liabilities | 491 | 493 | ||||||
| Current portion of long-term debt | 972 | 2,924 | ||||||
| Current portion of warranty liability | 113 | 199 | ||||||
| Total current liabilities | 29,329 | 21,549 | ||||||
| Long-term operating lease liabilities | 1,082 | 1,292 | ||||||
| Warranty liability | 937 | 966 | ||||||
| Other long-term liabilities | 1,388 | 1,389 | ||||||
| Total liabilities | 32,736 | 25,196 | ||||||
| Shareholders’ equity: | ||||||||
| Share capital: | ||||||||
| Unlimited common and preferred shares, no par value | ||||||||
| 18,995,734 (2025 - 17,351,005) common shares issued and outstanding | 1,247,185 | 1,246,793 | ||||||
| Other equity instruments | 8,898 | 8,968 | ||||||
| Additional paid in capital | 11,516 | 11,516 | ||||||
| Accumulated deficit | (1,174,983 | ) | (1,157,901 | ) | ||||
| Accumulated other comprehensive loss | (40,345 | ) | (40,563 | ) | ||||
| Total shareholders' equity | 52,271 | 68,813 | ||||||
| Total liabilities and shareholders' equity | $ | 85,007 | $ | 94,009 | ||||
Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) (unaudited) (Expressed in thousands of Three months ended | ||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Revenue | $ | 2,717 | $ | 12,498 | $ | 5,002 | $ | 19,821 | ||||||||
| Cost of revenue | 2,584 | 11,656 | 4,353 | 17,444 | ||||||||||||
| Gross profit | 133 | 842 | 649 | 2,377 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 1,211 | 1,574 | 2,434 | 2,867 | ||||||||||||
| General and administrative | 4,174 | 4,106 | 7,008 | 6,778 | ||||||||||||
| Sales and marketing | 224 | 290 | 431 | 733 | ||||||||||||
| Foreign exchange loss (gain) | 1,693 | (4,224 | ) | 2,700 | (5,427 | ) | ||||||||||
| Depreciation and amortization | 45 | 106 | 155 | 214 | ||||||||||||
| 7,347 | 1,852 | 12,728 | 5,165 | |||||||||||||
| Loss from operations | (7,214 | ) | (1,010 | ) | (12,079 | ) | (2,788 | ) | ||||||||
| Loss from investments accounted for by the equity method | (1,283 | ) | (3,686 | ) | (2,664 | ) | (7,570 | ) | ||||||||
| Change in fair value of warrant liability | (1,496 | ) | — | (1,496 | ) | — | ||||||||||
| Financing transaction costs | (1,085 | ) | — | (1,085 | ) | — | ||||||||||
| Interest on long-term debt | (68 | ) | (166 | ) | (158 | ) | (358 | ) | ||||||||
| Interest and other income, net of bank charges | (6 | ) | (147 | ) | 736 | 502 | ||||||||||
| Loss before income taxes | (11,152 | ) | (5,009 | ) | (16,746 | ) | (10,214 | ) | ||||||||
| Income tax expense | 223 | 44 | 336 | 134 | ||||||||||||
| Net loss from continuing operations | (11,375 | ) | (5,053 | ) | (17,082 | ) | (10,348 | ) | ||||||||
| Net income from discontinued operations | — | (29,291 | ) | — | (26,447 | ) | ||||||||||
| Net loss for the period | (11,375 | ) | (34,344 | ) | (17,082 | ) | (36,795 | ) | ||||||||
| Other comprehensive income (loss): | ||||||||||||||||
| Cumulative translation adjustment | 863 | 6,921 | 2,737 | 10,562 | ||||||||||||
| Ownership share of equity method investments' other comprehensive loss | (337 | ) | (1,464 | ) | (2,519 | ) | $ | (2,293 | ) | |||||||
| 526 | 5,457 | 218 | 8,269 | |||||||||||||
| Comprehensive loss | $ | (10,849 | ) | $ | (28,887 | ) | $ | (16,864 | ) | $ | (28,526 | ) | ||||
| Net loss per share: | ||||||||||||||||
| From continuing operations - basic and diluted | $ | (0.64 | ) | $ | (0.29 | ) | $ | (0.97 | ) | $ | (0.60 | ) | ||||
| From discontinued operations - basic and diluted | $ | — | (1.69 | ) | $ | — | (1.53 | ) | ||||||||
| Net loss per share - basic and diluted | $ | (0.64 | ) | $ | (1.98 | ) | $ | (0.97 | ) | $ | (2.12 | ) | ||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic and diluted | 17,822,491 | 17,338,288 | 17,609,725 | 17,330,527 | ||||||||||||
Condensed Consolidated Interim Statements of Cash Flows (unaudited) (Expressed in thousands of Three months ended | ||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Operating activities: | ||||||||||||||||
| Net loss for the period from continuing operations | $ | (11,375 | ) | $ | (5,053 | ) | $ | (17,082 | ) | $ | (10,348 | ) | ||||
| Adjustments to reconcile net income (loss) to net cash used in continuing operating activities: | ||||||||||||||||
| Depreciation and amortization | 255 | 219 | 467 | 397 | ||||||||||||
| Stock-based compensation expense | 110 | 126 | 196 | 304 | ||||||||||||
| Unrealized foreign exchange loss (gain) | 1,693 | (4,224 | ) | 2,700 | (5,427 | ) | ||||||||||
| Deferred income tax (recovery) | — | (6 | ) | — | (9 | ) | ||||||||||
| Loss from investments accounted for by the equity method | 1,283 | 3,686 | 2,664 | 7,570 | ||||||||||||
| Interest on long-term debt | 23 | 23 | 47 | 45 | ||||||||||||
| Inventory write-downs | 54 | 140 | 54 | 110 | ||||||||||||
| Bad debt expense | 14 | — | 2 | — | ||||||||||||
| Change in fair value of warrant liability | 1,496 | — | 1,496 | — | ||||||||||||
| Financing transaction costs | 1,085 | — | 1,085 | — | ||||||||||||
| Warranty provision | (124 | ) | — | (124 | ) | — | ||||||||||
| Net cash used before working capital changes | (5,486 | ) | (5,089 | ) | (8,495 | ) | (7,358 | ) | ||||||||
| Changes in working capital: | ||||||||||||||||
| Accounts receivable | (393 | ) | (8,160 | ) | 505 | (8,324 | ) | |||||||||
| Inventories | 159 | 5,879 | 197 | 3,770 | ||||||||||||
| Prepaid expenses | 498 | 600 | 524 | 920 | ||||||||||||
| Accounts payable and accrued liabilities | 647 | 1,056 | (675 | ) | (3,240 | ) | ||||||||||
| Warranty liability | 12 | 92 | 43 | 5 | ||||||||||||
| Net cash used in operating activities from continuing operations | (4,563 | ) | (5,622 | ) | (7,901 | ) | (14,227 | ) | ||||||||
| Net cash provided by (used in) operating activities from discontinued operations | — | (582 | ) | — | 3,125 | |||||||||||
| Investing activities: | ||||||||||||||||
| Purchase of property, plant and equipment | (48 | ) | (822 | ) | (480 | ) | (1,395 | ) | ||||||||
| Proceeds from holdback receivable | — | — | 5,844 | 10,450 | ||||||||||||
| Capital contributions to investments accounted for by the equity method | (3,512 | ) | (4,185 | ) | (6,364 | ) | (8,871 | ) | ||||||||
| Net cash provided by (used in) investing activities from continuing operations | (3,560 | ) | (5,007 | ) | (1,000 | ) | 184 | |||||||||
| Net cash used in investing activities from discontinued operations | — | (460 | ) | — | (2,947 | ) | ||||||||||
| Financing activities: | ||||||||||||||||
| Repayments of operating lines of credit and long-term facilities | (1,000 | ) | (1,000 | ) | (2,000 | ) | (2,000 | ) | ||||||||
| Proceeds from issuance of common share, warrants, and pre-funded warrants | 10,000 | — | 10,000 | — | ||||||||||||
| Payment of shares and warrants issuance costs | (700 | ) | 0 | (700 | ) | — | ||||||||||
| Net cash provided by (used in) financing activities from continuing operations | 8,300 | (1,000 | ) | 7,300 | (2,000 | ) | ||||||||||
| Net cash used in financing activities from discontinued operations | — | (3,176 | ) | — | (6,094 | ) | ||||||||||
| Effect of foreign exchange on cash and cash equivalents | (734 | ) | 4,593 | (1,611 | ) | 5,696 | ||||||||||
| Net decrease in cash and cash equivalents | (557 | ) | (11,254 | ) | (3,212 | ) | (16,263 | ) | ||||||||
| Cash and cash equivalents, beginning of period (including restricted cash) | 24,503 | 32,637 | 27,158 | 37,646 | ||||||||||||
| Cash and cash equivalents, end of period (including restricted cash) | $ | 23,946 | $ | 21,383 | $ | 23,946 | $ | 21,383 | ||||||||
| Less: cash and cash equivalents from discontinued operations, end of period (including restricted cash) | $ | — | $ | 15,319 | $ | — | $ | 15,319 | ||||||||
| Cash and cash equivalents from continuing operations, end of period (including restricted cash) | $ | 23,946 | $ | 6,064 | $ | 23,946 | $ | 6,064 | ||||||||
Source: